News | October 15, 2014

Douglas & Nancy Barnhart Cancer Center Uses New Software to Manage Risk for Patients With Cardiac Devices

The innovative technology platform for managing data from cardiac devices allows radiation oncologists to monitor for malfunction during radiation therapy

October 15, 2014 — The Geneva Healthcare Suite has been proven effective by clinicians at the Douglas & Nancy Barnhart Cancer Center at Sharp Chula Vista Medical Center in managing risk for patients with cardiac devices undergoing radiation therapy. The Barnhart Cancer Center presented the protocol “Risk Management for Lung Cancer Radiation Therapy and Cardiac Implantable Electronic Devices (CIEDs)” at the International Congress for Lung Cancer in August 2014.

“Therapeutic radiation for cancer can adversely affect cardiac device function even at relatively low scatter doses of radiation, putting the patient at risk,” said Siavash Jabbari, M.D., a radiation oncologist affiliated with the Barnhart Cancer Center who oversaw the use of the Geneva Healthcare Suite. “Guidelines exist for the assessment and management of these risks, but current clinical solutions are impractical and resource intensive. Before the Geneva Healthcare Suite we had to rely on local representatives from each device manufacturer to come in to interrogate the device. Now we have instant access to the information that helps us understand the status of the device.”

The Geneva Healthcare Suite has already been proven to cut emergency room wait times by an average of 92 minutes in a recent study published in the Academic Emergency Medicine Journal. The UCSD and Sharp Chula Vista Emergency Departments are using the suite to access data from incoming patients’ implanted cardiac devices such as pacemakers or defibrillators.

“We use the Geneva Healthcare Suite when patients with cardiac devices present at the emergency room because the platform organizes and presents the device data in a very intuitive dashboard that is consistent across all devices and immediately makes critical information available to all our clinicians, anytime and anywhere. We save time by making this information available immediately, which allows us to make faster decisions in the ER,” said Christina Ballejos, Ph.D., RN, CNS, Sharp Chula Vista. “It made sense to bring this technology to the Barnhart Cancer Center since patients with devices are also presenting for radiation treatments.”

The Geneva Healthcare Suite makes critical cardiac device data more accessible and available at the point of care. The suite organizes health data from multiple device sources on an intuitive dashboard that makes life-saving information available immediately to all clinicians.

For more information: genevahealthcare.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init